newsfilter
← Latest News
GlobeNewswire·

Bioasis Technologies enters into Convertible Security Funding Agreement for Institutional Investment of up to C$10 million

NEW HAVEN, Conn., June 22, 2021 (GLOBE NEWSWIRE) -- Bioasis Technologies Inc. ("Bioasis" or the "Company") ((TSX.V:BTI, OTCQB:BIOAF), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the